相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification
Dan L. Li et al.
CIRCULATION (2016)
SIRT1 Suppresses Doxorubicin-Induced Cardiotoxicity by Regulating the Oxidative Stress and p38MAPK Pathways
Yang Ruan et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2015)
The Novel Anthracenedione, Pixantrone, Lacks Redox Activity and Inhibits Doxorubicinol Formation in Human Myocardium: Insight to Explain the Cardiac Safety of Pixantrone in Doxorubicin-Treated Patients
Emanuela Salvatorelli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Downregulation of vitamin C transporter SVCT-2 in doxorubicin-induced cardiomyocyte injury
Ana R. Ludke et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2012)
Anthracycline cardiotoxicity
Pierantonio Menna et al.
EXPERT OPINION ON DRUG SAFETY (2012)
Subcellular basis of vitamin C protection against doxorubicin-induced changes in rat cardiomyocytes
Ana Ludke et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2012)
Characterization of autophagosome formation site by a hierarchical analysis of mammalian Atg proteins
Eisuke Itakura et al.
AUTOPHAGY (2010)
WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death
Balachandar Venkatesan et al.
CELLULAR SIGNALLING (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity
Masashi Yoshida et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Atrogin-1 ubiquitin ligase is upregulated by doxorubicin via p38-MAP kinase in cardiac myocytes
Yasuhiro Yamamoto et al.
CARDIOVASCULAR RESEARCH (2008)
Transformation of adult rat cardiac myocytes in primary culture
Tamas Banyasz et al.
EXPERIMENTAL PHYSIOLOGY (2008)
Chronic supplementation of creatine and vitamins C and E increases survival and improves biochemical parameters after doxorubicin treatment in rats
Ronaldo V. T. Santos et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2007)
p38 and ERK1/2 MAPKs mediate the interplay of TNF-α and IL-10 in regulating oxidative stress and cardiac myocyte apoptosis
Sanjiv Dhingra et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Mitochondrial and nuclear p53 localization in cardiomyocytes: Redox modulation by doxorubicin (adriamycin)?
Ramaneeya Nithipongvanitch et al.
ANTIOXIDANTS & REDOX SIGNALING (2007)
Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis
Kendall B. Wallace
CARDIOVASCULAR TOXICOLOGY (2007)
Role of mtDNA lesions in anthracycline cardiotoxicity
Dirk Lebrecht et al.
CARDIOVASCULAR TOXICOLOGY (2007)
JNK- and p38 kinase-mediated phosphorylation of Bax leads to its activation and mitochondrial translocation and to apoptosis of human hepatoma HepG2 cells
Bong-Jo Kim et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Matrix metalloproteinase-2 and-9 are induced differently by doxorubicin in H9c2 cells: The role of MAP kinases and NAD(P)H oxidase
P Spallarossa et al.
CARDIOVASCULAR RESEARCH (2006)
Involvement of oxidative stress in the pre-malignant and malignant states of cervical cancer in women
TL Gonçalves et al.
CLINICAL BIOCHEMISTRY (2005)
Involvement of mitogen-activated protein kinases in adriamycin-induced cardiomyopathy
H Lou et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2005)
Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism
LE Wold et al.
CANCER DETECTION AND PREVENTION (2005)
STRESS signaling pathways that modulate cardiac myocyte apoptosis
CP Baines et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Cardiovascular complications of cancer therapy - Diagnosis, pathogenesis, and management
ETH Yeh et al.
CIRCULATION (2004)
Anthracyclines: Molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity
G Minotti et al.
PHARMACOLOGICAL REVIEWS (2004)
Medical progress: Heart failure
M Jessup et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Nuclear extracellular signal-regulated kinase 2 phosphorylates p53 at Thr55 in response to doxorubicin
PY Yeh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)